R
Roberta L. Shanahan
Researcher at Kaiser Permanente
Publications - 5
Citations - 407
Roberta L. Shanahan is an academic researcher from Kaiser Permanente. The author has contributed to research in topics: Clinical pharmacy & Peer review. The author has an hindex of 4, co-authored 5 publications receiving 390 citations. Previous affiliations of Roberta L. Shanahan include University of Colorado Boulder.
Papers
More filters
Journal ArticleDOI
Effect of a Centralized Clinical Pharmacy Anticoagulation Service on the Outcomes of Anticoagulation Therapy
TL;DR: The cumulative evidence supporting the superior care associated with implementing a pharmacist-managed anticoagulation monitoring service was sufficient to recommend widespread implementation.
Journal ArticleDOI
Low myopathy rates associated with statins as monotherapy or combination therapy with interacting drugs in a group model health maintenance organization.
Roberta L. Shanahan,Jane A. Kerzee,Jane A. Kerzee,Brian G. Sandhoff,Nikki M. Carroll,John A. Merenich,John A. Merenich +6 more
TL;DR: The risk for myopathy increases when 3‐hydroxy‐3‐methylglutaryl coenzyme A inhibitors (statins) are used with other agents known to inhibit cytochrome P450 3A4 in patients with dyslipidemia, and a diverse, real‐world sample of patients receiving statin therapy was sought.
Journal ArticleDOI
Methadone for pain and the risk of adverse cardiac outcomes.
Lea C. Price,Lea C. Price,Lea C. Price,Brooke Wobeter,Thomas Delate,Thomas Delate,Deanna Kurz,Roberta L. Shanahan,Roberta L. Shanahan +8 more
TL;DR: Few cardiac adverse events resulting from methadone use for pain were detected, however, a large proportion of patients were at risk for an adverse event, especially patients who were older and had received ≥ 100 mg/day of methamphetamineadone.
Journal ArticleDOI
Implementation of a peer review process to improve documentation consistency of care process indicators in the EMR in a primary care setting.
TL;DR: The peer review process was successful in improving the consistency of documentation by PCCPS and compliance with existing standards and allows for sharing of best practices among high-functioning P CCPS practitioners who otherwise could remain isolated.
Journal ArticleDOI
A Descriptive Evaluation of Routine Complete Blood Count Monitoring in Patients Receiving Anticoagulation Therapy
TL;DR: Although routineCBC monitoring provides some utility in detecting occult bleeding, the yield of clinically important decreases in hemoglobin detected was low and, for most anticoagulated patients, routine CBC monitoring appears to be clinically unnecessary.